Edition:
United Kingdom

Blueprint Medicines Corp (BPMC.OQ)

BPMC.OQ on NASDAQ Stock Exchange Global Select Market

81.98USD
12 Dec 2017
Change (% chg)

$-6.34 (-7.18%)
Prev Close
$88.32
Open
$87.22
Day's High
$89.38
Day's Low
$80.22
Volume
326,262
Avg. Vol
151,584
52-wk High
$92.00
52-wk Low
$25.39

Select another date:

Mon, Dec 11 2017

BRIEF-Blueprint Medicines Announces Proposed Public Offering Of Shares Of Common Stock

* BLUEPRINT MEDICINES ANNOUNCES PROPOSED PUBLIC OFFERING OF SHARES OF COMMON STOCK

BRIEF-Blueprint Medicines announces new data from ongoing phase 1 clinical trial of BLU-285

* Blueprint Medicines announces new data from ongoing phase 1 clinical trial of BLU-285 in patients with advanced gastrointestinal stromal tumors showing strengthened clinical activity across spectrum of kit and pdgfrα genotypes

BRIEF-Thermo Fisher enters agreement with Blueprint Medicines​

* Thermo Fisher Scientific Inc - ‍ expanded development of Oncomine Dx Target Test by entering into an agreement with Blueprint Medicines Corporation​

BRIEF-Blueprint Medicines Q3 loss per share $0.96

* Blueprint Medicines reports third quarter 2017 financial results

BRIEF-Blueprint Medicines Q2 loss per share $0.86

* Blueprint Medicines reports second quarter 2017 financial results

BRIEF-Blueprint Medicines to evaluate advance disease discovery program opportunities

* Blueprint Medicines to evaluate opportunities to advance rare disease discovery program in fibrodysplasia ossificans progressiva following discontinuation of collaboration with Alexion

Select another date: